High glucose induces and activates Toll-like receptor 4 in endothelial cells of diabetic retinopathy

Diabetology & Metabolic Syndrome

Shao Bo Su¹  Xialin Liu¹  Hongyan Zhou¹  Jiazhu Fang¹  Jing Wang¹  Lu Wang² 

[1] State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China;Guangdong Province Hospital of Traditional Chinese Medicine, Guangzhou 510120, China

关键词: Angiogenesis;    Inflammation;    Endothelium;    Diabetic retinopathy;    Toll-like receptor 4;   

Others  :  1229626
DOI  :  10.1186/s13098-015-0086-4

 received in 2015-06-26, accepted in 2015-10-06,  发布年份 2015

【 摘 要 】

Background

Hyperglycemia-induced inflammation causes the dysfunction of blood vessels, and Toll-like receptor 4 (TLR4) plays a key role in inflammation-induced angiogenesis. However, the impact of TLR4 on the pathogenesis of diabetic retinopathy (DR) is poorly understood. In this study, we examined the expression of TLR4 in retinal vascular endothelial cells of patients with DR and diabetic mice, and explored the role of TLR4 in mediating inflammatory responses by human microvascular endothelial cells (HMEC-1) under high-glucose condition.

Methods

The expression of TLR4 in retinal vascular endothelial cells of patients with proliferative diabetic retinopathy and diabetic mice induced by streptozotocin was examined using immunofluorescence. HMEC-1 cells were cultured and the expression of TLR4, MyD88 and Interleukin-1β (IL-1β) was examined under high-glucose condition. Endothelial cells with TLR4 silencing and antagonist of TLR4 as well as endothelial cells from TLR4 deficient mice were used to study the effect of activated TLR4 on inflammation induced by high-glucose treatment.

Results

We observed that TLR4 was detected in CD31-labled human retinal vascular endothelia and its expression was markedly increased in fibrovascular membranes from DR patients and in retinal vascular endothelial cells of diabetic mice. The expression of TLR4, MyD88 and IL-1β was enhanced by high glucose in cultured HMEC-1 and the expression of TLR4 and IL-1β was inhibited by TLR4 siRNA knock-down and TLR4 antagonist. The expression of IL-1β by endothelial cells from TLR4 deficient mice under high glucose condition was decreased.

Conclusions

Our results revealed that hyperglycemia induced overexpression and activation of TLR4 in endothelial cells. This effect may lead to inflammatory responses contribute to the pathogenesis of diabetic retinopathy.

【 授权许可】

   
2015 Wang et al.

【 图 表 】

Fig.1.

Fig.2.

Fig.3.

Fig.4.

Fig.5.

Fig.6.

【 参考文献 】

• [1]Zheng L, Kern TS: Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy. Front Biosci 2009, 14:3974-3987.
• [2]Kocak N, Alacacioglu I, Kaynak S, et al. Comparison of vitreous and plasma levels of vascular endothelial growth factor, interleukin-6 and hepatocyte growth factor in diabetic and non-diabetic retinal detachment cases. Ann Ophthalmol (Skokie). 2010;42 Spec No: 10–4.
• [3]Bharadwaj AS, Appukuttan B, Wilmarth PA, et al.: Role of the retinal vascular endothelial cell in ocular disease. Prog Retin Eye Res 2013, 32:102-180.
• [4]Du XL, Edelstein D, Dimmeler S, et al.: Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 2001, 108:1341-1348.
• [5]Luppi P, Cifarelli V, Tse H, et al.: Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-kappaB pathway. Diabetologia 2008, 51:1534-1543.
• [6]Piga R, Naito Y, Kokura S, et al.: Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells. Atherosclerosis 2007, 193:328-334.
• [7]Esposito C, Fasoli G, Plati AR, et al.: Long-term exposure to high glucose up-regulates VCAM-induced endothelial cell adhesiveness to PBMC. Kidney Int 2001, 59:1842-1849.
• [8]Piconi L, Quagliaro L, Da Ros R, et al.: Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase. J Thromb Haemost 2004, 2:1453-1459.
• [9]Kawai T, Akira S: The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010, 11:373-384.
• [10]Devaraj S, Dasu MR, Rockwood J, et al.: Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 2008, 93:578-583.
• [11]Yang H, Tracey KJ: Targeting HMGB1 in inflammation. Biochim Biophys Acta 2010, 1799:149-156.
• [12]Ko MK, Saraswathy S, Parikh JG, et al.: The role of TLR4 activation in photoreceptor mitochondrial oxidative stress. Invest Ophthalmol Vis Sci 2011, 52:5824-5835.
• [13]Michelsen KS, Wong MH, Shah PK, et al.: Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 2004, 101:10679-10684.
• [14]Kaur H, Chien A, Jialal I: Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy. Am J Physiol Renal Physiol 2012, 303:F1145-F1150.
• [15]Buraczynska M, Baranowicz-Gaszczyk I, Tarach J, et al.: Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes. Hum Immunol 2009, 70:121-124.
• [16]Singh K, Kant S, Singh VK, et al.: Toll-like receptor 4 polymorphisms and their haplotypes modulate the risk of developing diabetic retinopathy in type 2 diabetes patients. Mol Vis 2014, 20:704-713.
• [17]Dasu MR, Devaraj S, Zhao L, et al.: High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 2008, 57:3090-3098.
• [18]Pal D, Dasgupta S, Kundu R, et al.: Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med 2012, 18:1279-1285.
• [19]Quagliaro L, Piconi L, Assaloni R, et al.: Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 2003, 52:2795-2804.
• [20]Dasu MR, Jialal I: Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors. Am J Physiol Endocrinol Metab 2011, 300:E145-E154.
• [21]Wang YL, Wang K, Yu SJ, et al. Association of the TLR4 signaling pathway in the retina of streptozotocin-induced diabetic rats. Graefe’s Arch Clin Exper Ophthalmol Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2015;253:389–98.
• [22]Devaraj S, Jialal I, Yun JM, et al.: Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications. Metabolism 2011, 60:256-259.
• [23]Lin M, Yiu WH, Wu HJ, et al.: Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J Am Soc Nephrol 2012, 23:86-102.
• [24]Singh K, Singh VK, Agrawal NK, et al.: Association of Toll-like receptor 4 polymorphisms with diabetic foot ulcers and application of artificial neural network in DFU risk assessment in type 2 diabetes patients. Biomed Res Int 2013, 2013:318686.
• [25]Kanhaiya AN, Gupta SK, Singh Kiran: Differential expression of toll like receptor 4 in type 2 diabetic patients with impaired wound healing. J Diabetes Metab 2013, 4:260.
• [26]de Kleijn D, Pasterkamp G: Toll-like receptors in cardiovascular diseases. Cardiovasc Res 2003, 60:58-67.
• [27]Lin Q, Yang XP, Fang D, et al.: High-mobility group box-1 mediates toll-like receptor 4-dependent angiogenesis. Arterioscler Thromb Vasc Biol 2011, 31:1024-1032.
• [28]He C, Sun Y, Ren X, et al.: Angiogenesis mediated by toll-like receptor 4 in ischemic neural tissue. Arterioscler Thromb Vasc Biol 2013, 33:330-338.
• [29]Yang S, Xu L, Yang T, et al.: High-mobility group box-1 and its role in angiogenesis. J Leukoc Biol 2014, 95:563-574.
• [30]Tang J, Kern TS: Inflammation in diabetic retinopathy. Prog Retin Eye Res 2011, 30:343-358.
• [31]Hsueh WA, Anderson PW: Hypertension, the endothelial cell, and the vascular complications of diabetes mellitus. Hypertension 1992, 20:253-263.
• [32]Jialal I, Huet BA, Kaur H, et al.: Increased toll-like receptor activity in patients with metabolic syndrome. Diabetes Care 2012, 35:900-904.
• [33]Dong B, Qi D, Yang L, et al.: TLR4 regulates cardiac lipid accumulation and diabetic heart disease in the nonobese diabetic mouse model of type 1 diabetes. Am J Physiol Heart Circ Physiol 2012, 303:H732-H742.
• [34]Chen X, Feng L, Jin H: Constant or fluctuating hyperglycemias increases cytomembrane stiffness of human umbilical vein endothelial cells in culture: roles of cytoskeletal rearrangement and nitric oxide synthesis. BMC Cell Biol 2013, 14:22. BioMed Central Full Text
• [35]Maeda M, Hayashi T, Mizuno N, et al.: Intermittent high glucose implements stress-induced senescence in human vascular endothelial cells: role of superoxide production by NADPH oxidase. PLoS One 2015, 10:e0123169.
• [36]Rajamani U, Jialal I: Hyperglycemia induces Toll-like receptor-2 and -4 expression and activity in human microvascular retinal endothelial cells: implications for diabetic retinopathy. J Diabetes Res 2014, 2014:790902.
• [37]Mudaliar H, Pollock C, Ma J, et al.: The role of TLR2 and 4-mediated inflammatory pathways in endothelial cells exposed to high glucose. PLoS One 2014, 9:e108844.
• [38]Lu Z, Li Y, Jin J, et al.: Toll-like receptor 4 activation in microvascular endothelial cells triggers a robust inflammatory response and cross talk with mononuclear cells via interleukin-6. Arterioscler Thromb Vasc Biol 2012, 32:1696-1706.
• [39]Hua KF, Wang SH, Dong WC, et al.: High glucose increases nitric oxide generation in lipopolysaccharide-activated macrophages by enhancing activity of protein kinase C-α/δ and NF-κB. Inflamm Res 2012, 61:1107-1116.